>>> US Research Calls II

Research Calls II
  • Upgrades:
    • Ecopetrol (EC) upgraded to Outperform from Neutral at Grupo Santander
    • Entergy (ETR) upgraded to Buy from Neutral at Ladenburg Thalmann; tgt $86.50
    • Planet Labs (PL) upgraded to Buy from Hold at Craig Hallum; tgt $7
  • Downgrades:
    • CARGO Therapeutics (CRGX) downgraded to Neutral from Buy at H.C. Wainwright
    • CARGO Therapeutics (CRGX) downgraded to Hold from Buy at Truist; tgt lowered to $7
    • CARGO Therapeutics (CRGX) downgraded to Underweight from Overweight at JP Morgan
    • CARGO Therapeutics (CRGX) downgraded to Mkt Perform from Outperform at William Blair
    • CARGO Therapeutics (CRGX) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $4
    • CARGO Therapeutics (CRGX) downgraded to Hold from Buy at Jefferies; tgt lowered to $3
    • CARGO Therapeutics (CRGX) downgraded to Neutral from Buy at Chardan Capital Markets
    • MeridianLink (MLNK) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $18
  • Others:
    • Alumis (ALMS) initiated with an Outperform at Oppenheimer; tgt $32
    • Foghorn Therapeutics (FHTX) initiated with a Buy at B. Riley Securities; tgt $10
    • Nextdoor (KIND) initiated with a Buy at Craig Hallum; tgt $4
    • Worthington Enterprises (WOR) initiated with a Buy at Seaport Research Partners; tgt $55

The Information : The Electric: Musk Confirms His Mission Has Changed: Make Tesl

The Electric: Musk Confirms His Mission Has Changed: Make Tesla a Lot More Valuable

In 19 minutes of remarks to analysts Wednesday evening, Tesla CEO Elon Musk enthused about his favorite topics—artificial intelligence-powered driverless cars and humanoid robots, which he predicted would make Tesla the most valuable company on Earth.

What Musk didn’t talk about: a quarter that in key ways was Tesla’s worst in at least four years; his plans for new or refreshed electric vehicles, its main current product and the source of almost all Tesla revenue; or the 800-pound gorilla in the room—how he is managing to run Tesla at all, given the massive amount of time he has spent helping President Donald Trump win reelection, prepare to return to the White House and now direct his administration.

Not that it mattered to the analysts—none asked about those topics. In a note to clients, Alexander Potter, an auto industry analyst with Piper Sandler, summed up the hourlong call: “Q4 Results weren’t great, but who cares? Elon has never sounded so bullish.”

As though in sync with Potter, investors pushed up the company’s shares more than 4% in after-hours trading.

Around this time last year, Musk essentially abandoned his mission—first publicly expressed in 2006—to put humanity into EVs and save the planet from climate change. As we reported last year, he canceled development of a $25,000 car for mainstream drivers and told lieutenants to instead develop a driverless taxi—a vehicle requiring no steering wheel or pedals—which he interchangeably dubbed the Robotaxi and the Cybercab. In revenue calls and public events, Musk said that the same AI that powered the Robotaxi would also power a humanoid robot called Optimus.

These two products—driverless cars and humanoid robots—would make Tesla worth $10 trillion, Musk said. Without them—just making EVs—Tesla would be “worth basically zero,” he said last June.

And it’s those two products that Musk spent most of Wednesday’s call speaking about. After deploying Robotaxis first in Austin, then in California, and then across the U.S., Musk said he would launch them in Europe and China. That would set up Tesla “for what I think will be an epic 2026 and a ridiculous 2027 and 2028—ridiculously good,” he said.

Meanwhile, Tesla’s robot team would develop Optimus, with plans to manufacture several thousand next year for use on mundane tasks in Tesla factories. In 2027, he predicted, the robot would be ready for sale outside Tesla. It would have the ability to play piano and thread a needle. “This is a level of precision no one has been able to achieve,” Musk said. “It’s really something special. My prediction long term is that Optimus will be overwhelmingly the value of the company.” Meaning the majority of that $10 trillion.

Tesla’s fourth-quarter report did not entirely ignore its EV traditions. In a slide deck posted on the company website before the call, Tesla reported that it would release an unspecified new, affordable EV in the first half of the year, and it forecast growth in annual car sales. Last year, Tesla’s EV sales fell for the first time since 2010. Tesla did not specify the company’s growth target for 2025.

But the deck seemed to underscore a primary reason for Musk’s change of heart about EVs—he doesn’t think Tesla can still make big profits from cars alone, or at least big enough to justify its $1.2 trillion valuation. In the fourth quarter, the company’s gross profit from vehicle sales excluding regulatory credits—payments from other companies to meet government clean vehicle thresholds—was 13.6%. That continued a slide that began in 2022, near the beginning of Tesla’s run of profitable quarters. In the first quarter of 2022, for instance, its automotive gross margin was 30%.

It's not clear that Musk is correct about EVs. Though Tesla’s profit margin is shrinking, it makes more money on EVs than anyone; its main rival, China’s Byd, earns a lot of its profit from the sale of plug-in hybrids. Nor is it self-evident that Robotaxis or humanoids will pan out the way Musk is predicting.

One possibility is that Musk has moved on from idealism—driverless cars and humanoid robots will not save the human race, but they could make a lot of profit.

With Wednesday’s call, Musk completed his transition from a man on a climate mission to one on a quest for profit and valuation.

>>> Manpower beats by $0.04, reports revs in-line; guides Q1 EPS below consensus

Manpower beats by $0.04, reports revs in-line; guides Q1 EPS below consensus
  • Reports Q4 (Dec) earnings of $1.02 per share, excluding non-recurring items, $0.04 better than the FactSet Consensus of $0.98; revenues fell 5.0% year/year to $4.4 bln vs the $4.4 bln FactSet Consensus.
  • Co issues downside guidance for Q1, sees EPS of $0.47-0.57, excluding non-recurring items, vs. $0.75 FactSet Consensus.
  • Jonas Prising, ManpowerGroup Chair & CEO, said, "The operating conditions experienced across our regions came in largely as expected during the quarter with relatively stable activity at lower levels across North America and Europe and good demand elsewhere. We took additional cost actions during the quarter, primarily in some of our most challenged European markets. Looking back at full year 2024, although difficult market conditions weighed heavily on our financial results, we competed well in many markets as a result of our Winning in the Market focus. We also made significant progress advancing our global transformation initiatives during 2024 and look forward to continuing our progress in 2025."

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Akero Therapeutics (AKRO) upgraded to Buy from Neutral at BofA Securities; tgt raised to $63
    • BlackLine (BL) upgraded to Buy from Underperform at BofA Securities; tgt raised to $75
    • Brinker (EAT) upgraded to Buy from Neutral at Northcoast; tgt $215
    • Coca-Cola (KO) upgraded to Buy from Hold at Jefferies; tgt raised to $75
    • Commvault Systems (CVLT) upgraded to Outperform from Mkt Perform at William Blair
    • Corning (GLW) upgraded to Buy from Hold at HSBC Securities; tgt raised to $60
    • CVS Health (CVS) upgraded to Buy from Hold at Edward Jones
    • Edwards Lifesciences (EW) upgraded to Buy from Hold at Stifel; tgt raised to $90
    • Lam Research (LRCX) upgraded to Overweight from Neutral at Cantor Fitzgerald; tgt $100
    • Lam Research (LRCX) upgraded to Outperform from Mkt Perform at Bernstein; tgt raised to $91
    • Logitech Int'l SA (LOGI) upgraded to Buy from Hold at Kepler
    • MercadoLibre (MELI) upgraded to Buy from Neutral at New Street; tgt raised to $2,300
    • Meta Platforms (META) upgraded to Buy from Hold at The Benchmark Company; tgt $820
    • Pacira BioSciences (PCRX) upgraded to Hold from Sell at Truist; tgt raised to $25
    • RH (RH) upgraded to Neutral from Sell at Goldman; tgt raised to $374
    • SEI Investments (SEIC) upgraded to Outperform from Mkt Perform at Raymond James; tgt $99
    • Veritex Holdings (VBTX) upgraded to Outperform from Market Perform at Hovde Group; tgt $31.50
  • Downgrades:
    • Everest Group (EG) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $375
    • Floor & Decor (FND) downgraded to Sell from Neutral at Goldman; tgt $79
    • KKR (KKR) downgraded to Hold from Buy at HSBC Securities; tgt $173
    • Lennox Int'l (LLI) downgraded to Neutral from Outperform at Mizuho; tgt lowered to $625
    • PagerDuty (PD) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $18
    • Vertex Pharma (VRTX) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $460
  • Others:
    • Knightscope (KSCP) initiated with a Buy at H.C. Wainwright; tgt $16
    • Surrozen (SRZN) initiated with a Buy at H.C. Wainwright; tgt $32

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • MBLY -13.1%, UPS -12.1%, WHR -12%, FLWS -10.9%, CI -9.7%, NOW -9.5% (also authorizes new $3 bln share repurchase program; also expands partnership with Google Cloud; also expands strategic alliance with Visa; also announces strategic partnership with SoftwareOne), DT -9.3%, MXL -8.4%, STM -8.2%, LEVI -6.8%, BFH -5.1%, ALGM -4.8%, TSCO -4.7%, MSFT -4.4%, AOS -4.4%, AVY -4.1%, SIGI -4%, MEOH -4%, DB -3.4%, CAT -3.4%, RHI -3.3%, CLB -2.9%, LUV -2.9%, DGX -2.9%, FIBK -2.6%, TTEK -2.2%, AXS -2.2%, SXC -2.2%, MUR -2%, DOW -2%, JBSS -1.9%, CMCSA -1.9%, TER -1.7%, NOC -1.7%, ETD -1.6%, CSWI -1.6%, SHW -1.6%, DLB -1.1%, WOLF -1%, CAH -0.8%
Other news:
  • CRGX -75.4% (to discontinue FIRCE-1)
  • IKT -11.1% (reports Phase 2 data on risvodetinib)
  • BFLY -10% (prices offering of 24.0 mln shares of common stock at $3.15 per share)
  • IMNM -9.7% (prices offering of 19,354,839 shares of its common stock at $7.75 per share)
  • IRWD -7% (initiates Apraglutide NDA submission; also sees FY25 revs below consensus)
  • TRIB -5.3% (provided an update as to the potential impact of U.S. President's Executive Order on Reevaluating and Realigning United States Foreign Aid on the Company's sales of Rapid HIV tests)
  • AAL -2.3% (American Airlines Flight 5342 collided in midair with a Sikorsky H-60 helicopter)
  • HRTG -2.1% (quantifies catastrophe losses from LA wildfires)
  • STBA -2.1% (raises dividend)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • CLS +13%, CALX +11%, IBM +8.1%, NOK +7.7%, OSK +7.7%, LVS +6.6%, LRCX +5.5%, FLG +5.4%, WDC +4.6%, MTH +4.5%, LAZ +4.3%, NFG +3.7%, CHKP +3.5%, SEIC +3.4%, BHE +3%, TAK +2.9%, PHM +2.9%, DOV +2.9%, SNY +2.8%, MBUU +2.7%, TWO +2.4%, ROP +2.2%, MMC +2.1%, BX +1.7%, TSLA +1.6%, AMP +1.4%, NLY +1.2%, CCS +1.2%, LSTR +1.2%, RES +1.2%, META +1.1%, SHEL +1.1%, CNX +1.1%, CP +0.9%, WM +0.9%, LHX +0.9%, RCI +0.8%
Other news:
  • TECX +40% (interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, TX45)
  • VBTX +23.3% (CFO to retire; names new CFO)
  • OFG +18.9% (increases dividend)
  • MXCT +4.7% (acquires SeQure Dx)
  • LAES +3.7% (expands its patent pool)
  • PESI +2.7% (names new COO)
  • STGW +2.6% (launches STAGE AI)
  • COUR +1.8% (CEO to retire, names new CEO)
  • ALLY +1.5% (CEO bought $1 mln in shares)
  • BALL +1.2% (authorizes new $4 bln share repurchase program)
  • UTL +1.2% (increases dividend)
  • CLMB +1.1% (names new chairman)
  • IIPR +1.1% (reached an agreement with PharmaCann Inc. and its affiliates to resolve PharmaCann's existing defaults under leases for eleven properties that the Company owns, previously announced by IIP on December 20, 2024)

>>> Europe : Brokers Upgrades & Downgrades - 30th of January 2025 V3(++)

>>> Up
* Aena Raised to Overweight at Barclays; PT 228 euros
* Almawave Raised to Buy at Banca Akros (ESN); PT 4 euros (+)
* ASML Raised to Buy at DZ Bank; PT 750 euros
* ASML ADRs PT Raised to $1,250 from $1,000 at Argus (++)
* Ceres Power Raised to Buy at Goldman; PT 220 pence
* Gecina Raised to Buy at HSBC; PT 107 euros
* IBM PT Raised to $275 from $240 at Evercore ISI (+)
* IBM PT Raised to $271 from $246 at Stifel (++)
* LEG Immobilien Raised to Buy at HSBC; PT 92 euros
* Lindt & Spruengli Raised to Buy at Redburn
* Logitech Raised to Buy at Kepler Cheuvreux
* Meta PT Raised to $785 from $690 at TD Cowen
* Netcompany Raised to Buy at SEB Equities; PT 350 kroner
* QleanAir Raised to Buy at Pareto Securities; PT 25 kronor
* Rotork Raised to Buy at Deutsche Bank; PT 405 pence (+)
* SAP ADRs PT Raised to $320 from $265 at Argus
* Sartorius Stedim Raised to Hold at Intron Health; PT 230 euros (+)
* Strix Raised to Buy at Shore Capital (+)
* SSAB Raised to Buy at DNB Markets; PT 65 kronor (+)
* TAG Immobilien Raised to Buy at HSBC; PT 16.50 euros
* Verkkokauppa.com Raised to Accumulate at Inderes; PT 1.90 euros

>>> Down
* Alliance Pharma Cut to Hold at Berenberg
* Avolta AG Cut to Hold at HSBC; PT 43 Swiss francs
* Generali Cut to Neutral at Banca Akros (ESN); PT 29 euros (+)
* Icade Cut to Hold at HSBC; PT 25 euros
* Leonardo Cut to Accumulate at Banca Akros (ESN); PT 32 euros (+)
* Multiconsult Cut to Hold at ABG; PT 215 kroner (+)
* Norconsult Norge Cut to Hold at ABG; PT 46 kroner (+)
* Nvidia PT Cut to $152 from $166 at Morgan Stanley
* Nvidia Cut to Sell at Punto Casa de Bolsa; PT $112
* Richemont Cut to Hold at Bank Vontobel; PT 185 Swiss francs
* Tesla PT Raised to $425 from $365 at Cantor (++)
* Thyssenkrupp Nucera Cut to Sell at Goldman; PT 8.70 euros
* Unibail Cut to Hold at HSBC; PT 85 euros

>>> Initiation
* Havas NV Rated New Neutral at JPMorgan; PT 1.90 euros
* VusionGroup Rated New Outperform at Bernstein; PT 220 euros (++)

>>> Call
* Aena Leads European Airports Higher Following Barclays Upgrade (++)
* Ceres Power Jumps as Goldman Upgrades After Underperformance (++)
* Fevertree’s Molson Coors Deal a ‘Game Changer,’ Jefferies Says (+)
* Rotork Gains as Deutsche Bank Upgrades on Scope for Re-Rating (++)
* Stolt-Nielsen Slips; DNB Sees Low-Quality 4Q Beat, Soft Guidance (++)
* Thyssenkrupp Nucera Slides as Goldman Cuts on US Hydrogen Market (++)
* Vitrolife Gains on 4Q as DNB Highlights Strong Margins (++)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • VBTX +23.3%, OFG +18.9%, CLS +12.4%, CALX +11%, NOK +8.6%, LAES +8.4%, IBM +7.9%, LRCX +7%, LVS +6.4%, FLG +5.9%, PESI +5.4%, MTH +4.5%, CHKP +4%, NFG +3.7%, TAK +3.5%, TSLA +3.1%, VIK +3%, BHE +3%, WDC +2.7%, STGW +2.6%, META +2.6%, SNY +2.6%, TWO +2.5%, COUR +2.3%, DOW +2.1%, ALLY +2%, SEIC +1.3%, SHEL +1.3%, UTL +1.2%, NLY +1.2%, CCS +1.2%, CLMB +1.1%, WM +1.1%, FNV +0.9%, AMGN +0.8%, WELL +0.8%
  • Gapping down:
    • CRGX -74.4%, WHR -12%, CI -11.7%, IKT -11.1%, BFLY -10.5%, IMNM -10.4%, NOW -9.3%, MXL -8.3%, STBA -7.7%, LEVI -7.5%, IRWD -7%, STM -6.8%, UPS -5.5%, ETD -5.1%, SIGI -4.1%, MEOH -4%, MSFT -3.8%, RHI -3.3%, MXCT -3%, DB -2.9%, AAL -2.3%, RJF -2.3%, AXS -2.2%, HRTG -2.1%, FBNC -1.9%, TTEK -1.8%, MUR -1.3%, FIBK -1.1%, DLB -1%, HWKN -0.9%

>>> UPS beats by $0.22, reports revs in-line; guides FY25 revs below consensus

UPS beats by $0.22, reports revs in-line; guides FY25 revs below consensus
  • Reports Q4 (Dec) earnings of $2.75 per share, excluding non-recurring items, $0.22 better than the FactSet Consensus of $2.53; revenues rose 1.5% year/year to $25.3 bln vs the $25.41 bln FactSet Consensus.
    • Consolidated Operating Margin of 11.6%; Non-GAAP Adjusted Consolidated Operating Margin of 12.3%.
  • Co issues downside guidance for FY25, sees FY25 revs of ~$89 bln vs. $95.03 bln FactSet Consensus.
    • Operating margin to be approximately 10.8%.
  • Today the company announces the following set of strategic actions:
    • First, it has reached an agreement in principle with its largest customer to lower its volume by more than 50% by the second half of 2026;
    • Second, effective January 1, 2025, the company has insourced 100% of its UPS SurePost product;
    • And third, in connection with these efforts, the company is reconfiguring its U.S. network, and launching multi-year "efficiency reimagined" initiatives to drive approximately $1.0 billion in savings through an end-to-end process redesign.
  • The company is planning capital expenditures of about $3.5 billion, dividend payments of around $5.5 billion, subject to board approval, and share repurchases of around $1.0 billion for 2025.

LYST : Lyst Index : Hottest Brand in Luxury in Q4 2024

The Lyst Index is a quarterly ranking of fashion’s hottest brands and products compiled by Lyst, the world's biggest and most intelligent fashion shopping platform. With 200m shoppers a year and the biggest data set in fashion, Lyst is a unique source of global fashion intelligence. The formula behind The Lyst Index takes into account Lyst shoppers’ behavior, including searches on and off platform, product views and sales. To track brand and product heat, the formula also incorporates social media mentions, activity and engagement statistics worldwide, over a three month period.


2024 was a year of fashion in flux, and the transformation of The Lyst Index hottest brands chart reveals how online fashion shoppers are responding to shifting tides. This was Miu Miu’s year; the brand claimed the number one spot three out of the last four quarters (displaced only by Loewe in Q2). Sister brand Prada has also remained within the Top 3 year-round, while Saint Laurent has been steadily climbing the Top 5. Meanwhile, the rest of the table continues to shuffle as fashion fans reassess the value of luxury labels, and (re)discover more accessible brands and trends. This quarter sees two new entrants, some seasonal success stories, and some dramatic leaps up and down the Hottest Brands chart.

Coach climbs 10 places to become the world’s 5th Hottest Brand, reflecting an exceptional quarter across all of our key Index metrics. A well-executed strategy to connect authentically with Gen Z customers has paid off, with demand up a staggering 65% quarter on quarter, and 332% year on year. Competitive discounts during Peak sale season allowed more customers to access hot Coach bags and made Coach pieces popular holiday gifts.

332%

The year on year increase in demand for Coach in 2024

The Coach Brooklyn bag is this quarter’s Hottest Product, with a 46% spike in searches for Q4, while a Coach cherry bag charm taps into the Gen-Z craze for customization. Accessories for accessories are trending, as shoppers look for quirky charms, pins, and scarves to express their personalities, and adorn their it-bags with a personal touch. Searches for bag charms on Lyst spiked 77% this quarter.

UGG, another Gen-Z favorite, breaks back into the Hottest Brands list, rocketing into tenth position. While UGG always sees seasonal success, this quarter’s demand is unprecedented; UGG searches are up 358% over the last three months, and up 12% year on year. Beyond the ongoing nostalgic appreciation for 2000s fashion, shoppers are feeling inspired by creators showcasing new ways to style the boots, pairing UGGs with baggy jeans or more elevated looks. As ‘Mini UGG outfit inspo’ dominated TikTok, the ubiquitous tan UGG Classic Ultra Mini Boots became this quarter’s second hottest product.
‍
Algorithms overlap in our Hottest Products ranking, where the data surfaces celeb-endorsed statement pieces alongside more pragmatic ‘capsule wardrobe’ items. Post quiet luxury, shoppers are still seeking sleek, clean design across all price points. The Row remains the quarter’s ninth hottest brand, while COS, H&M Group’s modern minimalist line, enters the Hottest Brands list for the first time. Demand for COS increased 16% this quarter, and its viral cashmere sweater (a dupe for The Row’s style) is the fifth hottest product.

The Wardrobe NYC RHW blazer dress, from a collaboration with actress and model Rosie Huntington-Whiteley, is this quarter’s sixth hottest product. As worn by Beyoncé at a Kamala Harris rally, searches increased 110% this quarter. Taylor Swift helped drive a 242% surge in searches for British designer Charlotte Simone’s cult vintage-inspired coats, this quarter’s eighth hottest product. While in ninth position, &Daughter’s cardigan is the it-knit of the season, representing a viral TikTok moment for red crew neck cardigans this winter.
‍
As TikTok continues to fuel brand and product heat, how could an evolving social media landscape in the US shape how we shop for fashion this year? Will the luxury downturn continue, opening up space for more premium and contemporary brands, and how will the comings and goings of fashion’s high-profile creative directors influence The Lyst Index? Fashion’s great shake-up looks set to continue into 2025, and we’ll be tracking the data as the story unfolds.

$628

The average price of a Q4 Hottest Product, down 27% YoY